541
Views
142
CrossRef citations to date
0
Altmetric
Research Article

Caffeic Acid Derivatives: In Vitro and In Vivo Anti-inflammatory Properties

, , , , , & show all
Pages 1241-1253 | Published online: 07 Jul 2009

References

  • Davis, K.L., Martin, E., Turko, IV. and Murad, F. (2001) "Novel effects of nitric oxide", Annu. Rev. Pharmacol. Toxicol. 41, 203–236.
  • Coleman, J.W. (2001) "Nitric oxide in immunity and inflammation", Int. Immunopharmacol. 1, 1397–1406.
  • Sheu, E, Lai, H.H. and Yen, G.C. (2001) "Suppression effect of soy isoflavones on nitric oxide production in RAW 264.7 macrophages", J. Agric. Food Chem. 49, 1767–1772.
  • Jolivalt, C.C., Howard, R.B., Chen, L.S., Mizisin, A.P. and Lai, CS. (2003) "A novel nitric oxide scavenger in combination with cyclosporine A ameliorates experimental autoimmune encephalonyelitis progression in mice", J. Neuroimmunol. 138, 56–64.
  • Mosi, R., Seguin, B., Cameron, B., Amankwa, L., Darkes, M.C. and Fricker, S.P. (2002) "Mechanistic studies on AMD6221: a ruthenium-based nitric oxide scavenger", Biochem. Biophys. Res. Commun. 292, 519–529.
  • Crosara-Alberto, D.P., Darini, A.L.C., Inoue, R.Y., Silva, J.S., Ferreira, S.H. and Cunha, F.Q. (2002) "Involvement of NO in the failure of neutrophil migration in sepsis induced by Staphylococcus aureus", Br. J. Pharmacol. 136, 645–658.
  • Marietta, M.A. (1994) "Approaches toward selective inhi-bition of nitric oxide synthase", J. Med. Chem. 37, 1899–1907.
  • Mayer, B. and Andrew, P. (1998) "Nitric oxide synthases: catalytic function and progress towards selective inhibition", Naunyn. Schmiedebergs. Arch. Pharmacol. 358, 127–133.
  • Connelly, L., Palacios-Callender, M., Ameixa, C., Moncada, S. and Hobbs, A.J. (2001) "Biphasic regulation of NF-KB activity underlies the pro- and anti-inflammatory actions of nitric oxide", J. Immunol. 166, 3873–3881.
  • Omote, K., Hazama, K., Kawamata, T., Kawamata, M., Nakayaka, Y, Toriyabe, M. and Namiki, A. (2001) "Peripheral nitric oxide in carrageenan-induced inflammation", Brain Res. 912, 171–175.
  • Tetsuka, T., Daphna-Iken, D., Miller, B.W., Guan, Z., Baier, L.D. and Morrison, A.R. (1996) "Nitric oxide amplifies interleukin 1-induced cyclooxigenase-2 expression in rat mesangial cells", J. Clin. Investig. 97, 2051–2056.
  • Sautebin, L., Ialenti, A., Ianaro, A. and Di Rosa, M. (1998) "Relationship between nitric oxide and prostaglandins in carrageenin pleurisy", Biochem. Pharmacol. 55, 1113–1117.
  • Handy, R.L.C. and Moore, P.K. (1998) "A comparison of the effects of L-NAME, 7-NI and L-NIL on carrageenan-induced hindpaw edema and NOS activity", Br. J. Pharmacol. 123, 1119–1126.
  • Cuzzocrea, S., Mazzon, E., Calabro, G., Dugo, L., Sarro, A., Van de Loo, F.A.J. and Caputi, A. (2000) "Inducible nitric oxide synthase knockout mice exhibit resistance to pleurisy and lung injury caused by carrageenan", Am. J. Respir. Crit. Care Med. 162, 1859–1866.
  • Rossi, A., Cuzzocrea, S., Mazzon, E., Serraino, I., De Sarro, A., Dugo, L., Felice, M.R., Van De Loo, F.A.J., Di Rosa, M., Musci, G., Caputi, A.P. and Sautebin, L. (2003) "Regulation of prostaglandin generation in carrageenan-induced pleurisy by inducible nitric oxide synthase in knockout mice", Life Sci. 72, 1199–1208.
  • Nardini, M., Pisu, E, Gentili, V., Natella, E, Di Felice, M., Piccolella, E. and Scaccini, C. (1998) "Effect of caffeic acid on tert-butyl hydropermdde-induced oxidative stress in U937", Free Radic. Biol. Med. 25, 1098–1105.
  • Kikuzaki, H., Hisamoto, M., Hirose, K., Akiyama, K. and Taniguchi, H. (2002) "Antioxidant properties of ferulic acid and its related compounds", J. Agric. Food Chem. 50, 2161–2168.
  • Silva, F.A.M., Borges, F., Guimardes, C., Lima, J.L.F.C., Matos, C. and Reis, S. (2000) "Phenolic acids and derivatives: studies on the relationship among structure, radical scavenging activity, and physicochemical parameters", J. Agric. Food Chem. 48, 2122–2126.
  • Castelluccio, C., Paganga, G., Melikian, N., Bolwell, G.P., Pridham, J., Sampson, J. and Rice-Evans, C. (1995) "Anti-oxidant potential of intermediates in phenylpropanoid metabolism in higher plants", FEBS Lett. 368, 188–192.
  • Kono, Y, Kobayashi, K., Tagawa, S., Adachi, K., Ueda, A., Sawa, Y. and Shibata, H. (1997) "Antioxidant activity of polyphenolics in diets. Rate constants of reactions of chlorogenic acid and caffeic acid with reactive species of oxygen and nitrogen", Biochim. Biophys. Acta 1335, 335–342.
  • Andreasen, M.F., Kroon, P.A., Williamson, G. and Garcia-Conesa, M.T. (2001) "Esterase activity able to hydrolyse dietary antioxidant hydroxycinnamates is distributed along the intestine of mammals", J. Agric. Food Chem. 49,5679–5684.
  • Tapiero, H., Tew, K.D., Nguyen, B.G. and Mathe, G. (2002) "Polyphenols: do they play a role in the prevention of human pathologies?", Biomed. Pharmacother. 56, 200–207.
  • Nardini, M., Leonardi, E, Scaccini, C. and Virgili, E (2001) "Modulation of ceramide-induced NF-KB binding activity and apoptotic response by caffeic acid in U937 cells: comparison with other antioxidants", Free Radic. Biol. Med. 30, 722–733.
  • Koshihara, Y, Neichi, T., Murota,Lao, A.-N., Fujimoto, Y.and Tatsuno, T. (1984) "Caffeic acid is a selective inhibitor for leukotriene biosynthesis", Biochim. Biophys. Acta 792, 92–97.
  • Nardini, M., Scaccini, C., Packer, L. and Virgili, E (2000) "In vitro inhibition on the activity of phosphorylase kinase, protein kinase C and protein kinase A by caffeic acid and a procyanidin rich pine bark (Pinus marittima) extract", Biochim. Biophys. Acta 1474, 219–225.
  • Natarajan, K., Singh, S., Burke, Jr., T.R., Grunberger, D. and Aggarwal, B.B. (1996) "Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-KB", Proc. Natl Acad. Sci. USA 93, 9090–9095.
  • Sud'Ina, G.F., Mirzoeva, O.K., Pushkareva, M.A., Korshu-nova, G.A., Sumbatyan, N.V. and Varfolomeev, S.D. (1993) "Caffeic acid phenethyl ester as a lipoxygenase inhibitor with antioxidant properties", FEBS Letts. 329, 21–24.
  • Michaluart, P., Masferrer, J.L., Carothers, A.M., Subbara-maiah, K., Zweifel, B.S., Kobolt, C., Mestre, J.R., Grunberger, D., Sacks, P.C., Tanabe, T. and Dannenberg, A.J. (1999) "Inhibitory effects of caffeic acid phenethyl ester on the activity and expression of cyclooxygenase-2 in human oral epithelial cells and in a rat model of inflammation", Cancer Res. 59, 2347–2352.
  • Song, Y.S., Park, E.-H., Hur, G.M., Ryu, YS., Lee, YS., Lee, J.Y., Kim, Y.M. and Jin, C. (2002) "Caffeic acid phenethyl ester inhibits nitric oxide synthase gene expression and enzyme activity", Cancer Lett. 175, 53–61.
  • Russo, A., Longo, R. and Vanella, A. (2002) "Antioxidant activity of propolis: role of caffeic acid phenethyl ester and galangin", Fitoterapia 73\(Suppl. 1), S21–S29.
  • Orban, Z., Mitsiades, N., Burke, Jr., T.R., Tsokos, M. and Chrousos, G.P. (1999) "Caffeic acid phenethyl ester induces leukocyte apoptosis, modulates nuclear factor-kappa B and suppresses acute inflammation", Neuroimmunomodulation 7, 99–105.
  • Borrelli, E, Maffia, P., Pinto, L., Ianaro, A., Russo, A., Capasso, F. and Ialenti, A. (2002) "Phytochemical compounds involved in the anti-inflammatory effect of propolis extract", Fit oterapia 73\(Suppl. 1), S53–S63.
  • Maffia, P., Ianaro, A., Pisano, B., Borrelli, F., Capasso, E, Pinto, A. and Ialenti, A. (2002) "Beneficial effects of caffeic acid phenethyl ester in a rat model of vascular injury", Br. J. Pharmacol. 136, 353–360.
  • Hsiao, G., Shen, M.-Y, Chang, W.-C., Cheng, Y-W., Pan, S.-L., Kuo, Y.-H., Chen, T.-E and Sheu, J.-R. (2003) "A novel antioxidant, octyl caffeate, supresses LPS/IFN-y-induced inducible nitric oxide synthase gene expression in rat aortic smooth muscle cells", Biochem. Pharmacol. 7598, 1–10.
  • Sautebin, L. (2000) "Prostaglandins and nitric oxide as molecular targets for anti-inflammatory therapy", Fit oterapia 71, S48–S57.
  • Kourounakis, A.P., Galanakis, D., Tziakitzis, K., Rekka, E.A. and Kourounakis, P.N. (1999) "Synthesis and pharmacologi-cal evaluation of novel derivatives of anti-inflammatory drugs with increased antioxidant and anti-inflammatory activities", Drug Dev. Res. 47, 9–16.
  • Mayo, D.W., Piked, R.M. and Trumper, P.K. (1994) Microscale Organic Laboratory with Multistep and Multiscale Synthesis (Wiley, New York).
  • Nudelman, Y, Bechor, E., Falb, B. and Fischer, B.A. (1998) "Carboxilic acids and esters", Synth. Commun. 28, 471.
  • Zimmermman, M. (1983) "Ethical guidelines for investi-gations of experimental pain in conscious animals", Pain 16, 109–110.
  • Van de Loosdrecht, A.A., Nennie, E., Ossenkoppele, G.J., Beelen, R.H. and Langenhuijen, M.M. (1991) "Cell mediated citotoxicity against U937 cells by human monocytes and macrophages in a modified colorimetric MTT assay. A metodological study", J. Immunol. Methods 141(1), 15–22.
  • Bredt, D.S. and Snyder, S.H. (1990) "Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme", Proc. Natl Acad. Sci. 87, 682–685.
  • Bradford, UM. (1976) "A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding", Anal. Biochem. 72,248–254.
  • Campos, MM. and Calixto, J.B. (1995) "Involvement of B1 and B2 receptors in bradykinin-induced rat paw edema", Br. J. Pharmacol. 114, 1005–1013.
  • Francischi, J.N., Yokoro, CM., Poole, S., Tarufi, W.L., Cunha, F.Q. and Teixeira, UM. (2000) "Anti-inflammatory and analgesic effects of the phosphodiesterase 4 inhibitor rolipram in a rat model of arthritis", Fur. J. Pharmacol. 399, 243–249.
  • De Young, L.M., Kheifets, J.B., Ballararon, S.J. and Young, J.M. (1989) "Edema and cell infiltration in the phorbol ester-treated mouse ear are temporally separate and can be differentially modulated by pharmacologic agents", Agents Actions 26, 335–341.
  • Nagaoka, T., Banskota, A.H., Tezuka, Y., Midorikawa, K., Matsushige, K. and Kadota, S. (2003) "Caffeic acid phenethyl ester (CAPE) analogues: potent nitric oxide inhibitors from the Netherland propolis", Biol. Pharm. Bull. 26, 487–491.
  • Cartron, E., Carbonneau, M.-A., Fouret, G., Descomps, B. and Leger, C.L. (2001) "Specific antioxidant activity of caffeoyl derivatives and other natural phenolic compounds: LDL protection against oxidation and decrease in the proinflam-matory lysophosphatidylcholine production", J. Nat. Prod. 64, 480–486.
  • Chen, J.H. and Ho, C.-T. (1997) "Antioxidant activities of caffeic acid and its related hydroxycinnamic acid com-pounds", J. Agric. Food Chem. 45, 1274–1278.
  • Monpied, P., Bock, E, Rondouin, G., Niel, G., Briant, L., Courseau, A.-S., Lerner-Natoli, M. and Bockaert, J. (2003) "Caffeic acid phenethyl ester (CAPE) prevents inflammatory stress in organotypic hippocampal slice cultures", Mol. Brain Res. 115, 111–120.
  • Fitzpatrick, L.R., Wang, J. and Le, T. (2001) "Caffeic acid phenethyl ester, an inhibitor of nuclear factor-KB, attenuates bacterial peptidoglycan polysaccharide-induced colitis in rats", J. Pharmacol. Exp. Ther. 299, 915–920.
  • Calikoglu, M., Tamer, L., Sucu, N., Coskun, B., Ercan, B., Gul, A., Calikoglu, I. and Kanik, A. (2003) "The effects of caffeic acid phenethyl ester on tissue damage in lung after hindlimb ischemia-reperfusion", Pharm. Res. 48, 397–403.
  • Santolini, J., Meade, A.L. and Stuehr, D.J. (2001) "Differences in three kinetic parameters underpin the unique catalytic profiles of nitric-oxide synthases I, II and BI", J. Biol. Chem. 276, 48887–48898.
  • Assreuy, J., Cunha, F.Q., Liew, F.Y. and Moncada, S. (1993) "Feedback inhibition of nitric oxide synthase activity by nitric oxide", Br. J. Pharmacol. 108, 833–837.
  • Ravi, K., Brennan, L.A., Levic, S., Ross, P.A. and Black, S.M. (2004) "S-nitrosylation of endothelial nitric oxide synthase is associated with monomerization and decreased enzyme activity", Proc. Natl Acad. Sci. 101(8), 2619–2624.
  • Griscavage, J.M., Hobbs, A.J. and Ignarro, L.J. (1995) "Negative modulation of nitric oxide synthase by nitric oxide and nitroso compounds", Adv. Pharmacol. 34, 215–234.
  • Dlaska, M. and Weiss, G. (1999) "Central role of transcription factor NF-1L6 for cytokine and iron-mediated regulation of murine inducible nitric oxide synthase expression", J. Immunol. 162, 6171–6177.
  • Vinegar, R., Truax, J.F., Selph, J.L., Johnston, P.R., Venable, A.L. and Mckenzie, K.K. (1987) "Pathway to carrageenan-induced inflammation in the hind limb of the rat", FASEB J. 46, 118–126.
  • Salvemini, D., Wang, Z.-Q., Bourdon, D.M., Stern, M.K., Currie, M.G. and Manning, P.T. (1996) "Evidence of permdnitrite involvement in the carrageenan-induced rat paw edema", Fur. J. Pharmacol. 203, 217–220.
  • Henriques, M.G.M.O., Silva, P.M.R., Martins, M.A., Flores, C.A., Cunha, EQ., Assreuy, J. and Cordeiro, R.S.B. (1987) "Mouse paw edema. A new model for inflammation?", Braz. J. Med. Biol. Res. 20, 243–249.
  • Dinarello, C.A. (1988) "Interleukin-1", Ann. NY Acad. Sci. 546, 122–132.
  • Zang, Y, Wang, J.-Z., Wu, Y.-J. and Li, W.-G. (2002) "Anti-inflammatory effect of recombinant human superoxide dismutase in rats and mice and its mechanism", Acta Pharmacol. Sin. 23, 439–444.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.